Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 1/2019

12.04.2019 | leitlinien für die praxis

Kontinuierliche Glukosemessung (CGM – Continuous Glucose Monitoring) bei Diabetes mellitus (Update 2019)

verfasst von: Ingrid Schütz-Fuhrmann, Birgit Rami-Merhar, Sabine E. Hofer, Elke Fröhlich-Reiterer, Julia Mader, Marietta Stadler, Martin Bischof, Sandra Zlamal-Fortunat, Markus Laimer, Raimund Weitgasser

Erschienen in: Wiener klinische Wochenschrift | Sonderheft 1/2019

Einloggen, um Zugang zu erhalten
share
TEILEN

Zusammenfassung

Die Leitlinie repräsentiert die Empfehlungen der Österreichischen Diabetes Gesellschaft (ÖDG) zur diagnostischen und therapeutischen Anwendung der kontinuierlichen Glukosemessung bei Erwachsenen und Kindern mit Diabetes mellitus, basierend auf der zurzeit zur Verfügung stehenden Evidenz.
Literatur
1.
Zurück zum Zitat Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA. STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311–20. CrossRef Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA. STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311–20. CrossRef
2.
Zurück zum Zitat Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006;29(12):2730–2. CrossRef Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006;29(12):2730–2. CrossRef
3.
Zurück zum Zitat Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009;32(8):1378–83. CrossRef Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009;32(8):1378–83. CrossRef
4.
Zurück zum Zitat Kordonouri O, Pankowska E, Rami B, Kapellen T, Coutant R, Hartmann R, Lange K, Knip M, Danne T. Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study(ONSET) after 12 months of treatment. Diabetologia. 2010;53(12):2487–95. CrossRef Kordonouri O, Pankowska E, Rami B, Kapellen T, Coutant R, Hartmann R, Lange K, Knip M, Danne T. Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study(ONSET) after 12 months of treatment. Diabetologia. 2010;53(12):2487–95. CrossRef
6.
Zurück zum Zitat Rachmiel M, Landau Z, Boaz M, Mazor Aronovitch K, Loewenthal N, Ben-Ami M, Levy-Shraga Y, Modan-Moses D, Haim A, Abiri S, Pinhas-Hamiel O. The use of continuous glucose monitoring systems in a pediatric population with type 1 diabetes mellitus in real-life settings: the AWeSoMe Study Group experience. Acta Diabetol. 2015;52(2):323–9. https://​doi.​org/​10.​1007/​s00592-014-0643-6. CrossRefPubMed Rachmiel M, Landau Z, Boaz M, Mazor Aronovitch K, Loewenthal N, Ben-Ami M, Levy-Shraga Y, Modan-Moses D, Haim A, Abiri S, Pinhas-Hamiel O. The use of continuous glucose monitoring systems in a pediatric population with type 1 diabetes mellitus in real-life settings: the AWeSoMe Study Group experience. Acta Diabetol. 2015;52(2):323–9. https://​doi.​org/​10.​1007/​s00592-014-0643-6. CrossRefPubMed
8.
Zurück zum Zitat Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S, Biester T, Stefanija MA, Muller I, Nimri R, Danne T. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Eng J Med. 2013;368:824–33. CrossRef Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S, Biester T, Stefanija MA, Muller I, Nimri R, Danne T. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Eng J Med. 2013;368:824–33. CrossRef
9.
Zurück zum Zitat Tauschmann M, Allen JM, Wilinska ME, Thabit H, Acerini CL, Dunger DB, Hovorka R. Home use of day-and night hybrid closed-loop insulin delivery in suboptimally controlled adolsecents with type 1 diabetes: a 3‑week, free living, randomized crossover trial. Diabetes Care. 2016;39(11):2019–25. CrossRef Tauschmann M, Allen JM, Wilinska ME, Thabit H, Acerini CL, Dunger DB, Hovorka R. Home use of day-and night hybrid closed-loop insulin delivery in suboptimally controlled adolsecents with type 1 diabetes: a 3‑week, free living, randomized crossover trial. Diabetes Care. 2016;39(11):2019–25. CrossRef
10.
Zurück zum Zitat Tauschmann M, Hovorka R. Technology in the management of type 1 diabetes mellitus – current status and future prospects. Nat Rev Endocrinol. 2018;14:464–75. CrossRef Tauschmann M, Hovorka R. Technology in the management of type 1 diabetes mellitus – current status and future prospects. Nat Rev Endocrinol. 2018;14:464–75. CrossRef
11.
Zurück zum Zitat Del Favero S, Boscari F, Messori M, Rabbone I, Bonfanti R, Sabbion A, Iafusco D, Schiaffini R, Visentin R, Calore R, Moncada YL, Galasso S, Galderisi A, Vallone V, Di Palma F, Losiouk E, Lanzola G, Tinti D, Rigamonti A, Marigliano M, Zanfardino A, Rapini N, Avogaro A, Chernavvsky D, Magni L, Cobelli C, Bruttomesso D. Randomized summer camp crossover trial in 5‑ to 9‑year-old children: outpatient wearable artificial pancreas is feasible and safe. Diabetes Care. 2016;39(7):1180–5. https://​doi.​org/​10.​2337/​dc15-2815. CrossRefPubMed Del Favero S, Boscari F, Messori M, Rabbone I, Bonfanti R, Sabbion A, Iafusco D, Schiaffini R, Visentin R, Calore R, Moncada YL, Galasso S, Galderisi A, Vallone V, Di Palma F, Losiouk E, Lanzola G, Tinti D, Rigamonti A, Marigliano M, Zanfardino A, Rapini N, Avogaro A, Chernavvsky D, Magni L, Cobelli C, Bruttomesso D. Randomized summer camp crossover trial in 5‑ to 9‑year-old children: outpatient wearable artificial pancreas is feasible and safe. Diabetes Care. 2016;39(7):1180–5. https://​doi.​org/​10.​2337/​dc15-2815. CrossRefPubMed
13.
Zurück zum Zitat Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Use of flash glucose-sensing technology for 12 months as a replacement for blood glucose monitoring in insulin-treated type 2 diabetes. Diabetes Ther. 2017;8(3):573–86. CrossRef Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Use of flash glucose-sensing technology for 12 months as a replacement for blood glucose monitoring in insulin-treated type 2 diabetes. Diabetes Ther. 2017;8(3):573–86. CrossRef
15.
Zurück zum Zitat Feig DS, Donovan LE, Corcoy R, Murphy KE, Amiel SA, Hunt KF, Asztalos E, Barrett JFR, Sanchez JJ, de Leiva A, Hod M, Jovanovic L, Keely E, McManus R, Hutton EK, Meek CL, Stewart ZA, Wysocki T, O’Brien R, Ruedy K, Kollman C, Tomlinson G, Murphy HR, CONCEPTT Collaborative Group. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017;390(10110):2347–59. https://​doi.​org/​10.​1016/​S0140-6736(17)32400-5. Erratum in: Lancet. 2017 Nov 25;390(10110):2346. CrossRefPubMedPubMedCentral Feig DS, Donovan LE, Corcoy R, Murphy KE, Amiel SA, Hunt KF, Asztalos E, Barrett JFR, Sanchez JJ, de Leiva A, Hod M, Jovanovic L, Keely E, McManus R, Hutton EK, Meek CL, Stewart ZA, Wysocki T, O’Brien R, Ruedy K, Kollman C, Tomlinson G, Murphy HR, CONCEPTT Collaborative Group. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017;390(10110):2347–59. https://​doi.​org/​10.​1016/​S0140-6736(17)32400-5. Erratum in: Lancet. 2017 Nov 25;390(10110):2346. CrossRefPubMedPubMedCentral
Metadaten
Titel
Kontinuierliche Glukosemessung (CGM – Continuous Glucose Monitoring) bei Diabetes mellitus (Update 2019)
verfasst von
Ingrid Schütz-Fuhrmann
Birgit Rami-Merhar
Sabine E. Hofer
Elke Fröhlich-Reiterer
Julia Mader
Marietta Stadler
Martin Bischof
Sandra Zlamal-Fortunat
Markus Laimer
Raimund Weitgasser
Publikationsdatum
12.04.2019
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe Sonderheft 1/2019
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-019-1465-x